Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04256980 |
|---|---|
| Brief Title: | Pemigatinib in Treating Patients With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Rearrangement |
| First Submitted : | January 20, 2020 |
| First Submitted that Met QC Criteria : | February 4, 2020 |
| First Posted : | February 5, 2020 |
| Last Update Submitted that Met QC Criteria : | October 3, 2022 |
| Last Update Posted : | October 4, 2022 |